Columns

Mia!

MEET MIA!

This week’s shelter pet is Mia, a loving and energetic two year-old Pit/Lab Mix currently waiting at the Smithtown Animal Shelter for her furever home.

Equal parts goofy and affectionate, Mia came to the shelter as a stray after being hit by a car and fortunately sustaining only minor injuries. She loves to whip around her rope toys and chase after balls and thinks she is a lap dog and will crawl in your lap and shower you with kisses.

Mia was a yard dog, so she is protective of her space when it comes to strangers, and she will require a home that can properly introduce her to new people. Once she meets a new friend, she loves them unconditionally. Mia would be best as the only pet in the home. She comes spayed, up to date on her vaccines and microchipped.

If you are interested in meeting Mia, please call ahead to schedule an hour to properly interact with her in a domestic setting, which includes a Meet and Greet Room, the dog runs, and a Dog Walk trail. Family Pet Meet and Greets and at home interactions are also welcome and an integral part of the adoption process.

The Smithtown Animal & Adoption Shelter is located at 410 Middle Country Road, Smithtown. Shelter operating hours are 8 a.m. to 5 p.m. during the week, 8 a.m. to 4:30 p.m. on the weekend. For more information, please call 631-360-7575 or visit www.smithtownanimalshelter.com.

by -
0 75
Motor. Photo courtesy of Smithtown Animal Shelter

MEET MATTY, MOTOR AND SID!

Shy cats need love too! 

This week’s shelter pets are, from top, Matty, Motor and Sid, 1-year-old cats at the Smithtown Animal Shelter that are overlooked time and again because they are shy. 

All 3 grew up in the shelter and watched their more outgoing siblings get happy homes. They may take time to let you in, but when they do, they are loving, playful and sweet. These three boys are buds but not bonded. They’d love to be homed together, but will adjust if they aren’t. 

Shy cats need quiet homes with patience and lots of love to give but  they are worth it! The trio come spayed, microchipped and is up to date on their vaccines.

If you are interested in meeting  Matty, Motor and Sid, please call ahead to schedule an hour to properly interact with them.

The Smithtown Animal & Adoption Shelter is located at 410 Middle Country Road, Smithtown. Shelter operating hours are 8 a.m. to 5 p.m. during the week, 8 a.m. to 4:30 p.m. on the weekend. For more information, please call 631-360-7575 or visit www.smithtownanimalshelter.com.

Statins may be overprescribed for the primary prevention of cardiovascular disease. Stock photo
Do primary prevention benefits outweigh the risks?

By David Dunaief, M.D.

Dr. David Dunaief

Statins were first approved in the U.S. over 30 years ago. Today, they are one of the most commonly prescribed medications in the United States. Yet, many in the medical community still disagree about who should be taking a statin and for what purpose; some believe that more patients should be on this class of drugs, while others think it is overprescribed. This is one of the most polarizing issues in medicine — probably rightly so.

The biggest debate is over primary prevention with statins. Primary prevention is treating people with high cholesterol and/or inflammation who may be at risk for a cardiovascular event, such as a stroke or heart attack. Currently, recommendations of the American College of Cardiology and the American Heart Association do not align with those of the U.S. Preventive Services Task Force, which is currently reviewing its own recommendations because of data updates.

Most physicians agree that statins have their place in secondary prevention — treating patients who have had a stroke or heart attack already or who have coronary artery disease.

We will examine benefits and risks for the patient population that could take statins for primary prevention. On one side are those who point to statins’ benefits: reduced cancer risk, improved quality of life and lowered glaucoma risk. On the other, we have those who note statins’ side effects: increased diabetes risk, fatigue and cataracts, to name a few. Let’s look at some of the evidence.

Effect on cancer

A study published in The New England Journal of Medicine involved 300,000 Danish participants and investigated 13 cancers. It showed that statin users may have a 15 percent decreased risk of death from cancer (1). As you can imagine, this news was greeted with excitement.

However, there were major limitations with the study. First, researchers did not control for smoking, which we know is a large contributor to cancer. Second, it was unknown which of the statin-using population might have received conventional cancer treatments, such as radiation and chemotherapy. Third, the dose of statins did not correlate to risk reduction. In fact, those who took 1 to 75 percent of prescribed statin levels showed more benefit in terms of cancer mortality risk than those who took more. We need a better-designed trial to determine whether there really is an effect.

Another study, a meta-analysis of 13 observational studies, showed that statins may play a role in reducing the risk of esophageal cancer. This is important, since esophageal cancer, especially adenocarcinoma that develops from Barrett’s esophagus, is on the rise. The results showed a 28 percent risk reduction in this type of cancer. The authors of the study surmise that statins may have a protective effect (2).

Although there is an association, these results need to be confirmed with randomized controlled trials. Aspirin has about the same 30 percent reduction in colorectal cancer, yet is not recommended solely for this use because of side effects.

Eye diseases: mixed results

In two common eye diseases, glaucoma and cataracts, statins have vastly different results. In one study, statins were shown to decrease the risk of glaucoma by five percent over one year and nine percent over two years (3). It is encouraging that the longer the duration of statin use, the greater the positive effect on preventing glaucoma.

Statins also help to slow glaucoma progression in patients suspected of having early-stage disease at about the same rate. This was a retrospective study analyzing statin use with patients at risk for open-angle glaucoma. We need prospective (forward-looking) studies. With cataracts, it is a completely different story. Statins increase the risk of cataracts by over 50 percent, as shown in the Waterloo Eye Study (4). Statins exacerbate the risk of cataracts in an already high-risk group, diabetes patients.

Quality of life and longevity: a mixed bag

In a meta-analysis involving 11 randomized controlled trials, statins did not reduce the risk of all-cause mortality in moderate to high-risk primary prevention participants (5). This study analysis involved over 65,000 participants with high cholesterol and at significant risk for heart disease.

However, in this same study, participants at high risk of coronary heart disease saw a substantial improvement in their quality of life with statins. In other words, the risk of a nonfatal heart attack was reduced by more than half and nonfatal strokes by almost half, avoiding the potentially disabling effects of these events.

Fatigue effect

Some of my patients who are on statins ask if statins can cause fatigue. A randomized controlled trial published in the Archives of Internal Medicine reinforces the idea that statins increase the possibility of fatigue (6).

Women, especially, complained of lower energy levels, both overall and on exertion, when they were blindly assigned to a statin-taking group. The trial had three groups: two that took statins, simvastatin 20 mg and pravastatin 40 mg; and a placebo group. The participants were at least 20 years old and had LDL (bad) cholesterol of 115 to 190 mg/dl, with less than 100 mg/dl considered ideal.

In conclusion, some individuals who are at high risk for cardiovascular disease may need a statin, but with the evidence presented, it is more likely that statins are overprescribed in primary prevention. Evidence of the best results points to lifestyle modification, with or without statins, and all patients with elevated LDL (bad) cholesterol should make changes that include a nutrient-dense diet and a reduction in fat intake, as well as exercise.

References:

(1) N Engl J Med 2012;367:1792-1802. (2) Clin Gastroenterol Hepatol. 2013 Jun; 11(6):620–629. (3) Ophthalmology 2012;119(10):2074-2081. (4) Optom Vis Sci 2012;89:1165-1171. (5) Arch Intern Med 2010;170(12):1024-1031. (6) Arch Intern Med 2012;172(15):1180-1182.

Dr. David Dunaief is a speaker, author and local lifestyle medicine physician focusing on the integration of medicine, nutrition, fitness and stress management. For further information, visit www.medicalcompassmd.com. 

Michael Schatz and Aspyn Palatnick. Photo by Lauryl Palatnick

By Daniel Dunaief

Michael Schatz, Adjunct Associate Professor at Cold Spring Harbor Laboratory, saw some similarities to his own life when he met the then 14-year old Aspyn Palatnick.

Palatnick, who was a student at Cold Spring Harbor High School, had been developing games for the iPhone. When he was that age, Schatz, who is also a Bloomberg Distinguished Associate Professor of Computer Science and Biology at Johns Hopkins University, stayed up late into the evening programming his home computer and building new software systems.

Meeting Palatnick eight years ago was a “really special happenstance,” Schatz said. He was “super impressed” with his would-be young apprentice.

When he first met Schatz, Palatnick explained in an email that he “realized early on that he would be an invaluable mentor across research, computer science, and innovation.”

Palatnick was looking for the opportunity to apply some of the skills he had developed in making about 10 iPhone games, including a turtle racing game, to real-world problems.

Knowing that Palatnick had no formal training in computer science or genetics, Schatz spent the first several years at the white board, teaching him core ideas and algorithms.

“I was teaching him out of graduate student lecture notes,” Schatz said.

Schatz and Palatnick, who graduated with a bachelors and master’s from the University of Pennsylvania and works at Facebook, have produced a device which they liken to a “tricorder” from Star Trek. Using a smart phone or other portable technology, the free app they created called iGenomics is a mobile genome sequence analyzer.

The iPhone app complements sequencing devices Oxford Nanopore manufactures. A mobile genetic sequencer not only could help ecologists in the field who are studying the genetic codes for a wide range of organisms, but it could also be used in areas like public health to study the specific gene sequences of viruses like SARS-CoV-2, which causes COVID-19.

In a paper published in GigaScience, Schatz and Palatnick describe how to use iGenomics to study flu genomes extracted from patients. They also have a tutorial on how to use iGenomics for COVID-19 research.

While developing the mobile sequencing device wasn’t the primary focus of Schatz’s work, he said he and others across numerous departments at Johns Hopkins University spent considerable time on it this summer, as an increasing number of people around the world contracted the virus.

“It very rapidly became how I was spending the majority of my time,” said Schatz.

Palatnick is pleased with the finished product.

“We’ve made DNA sequence analysis portable for the first time,” he explained in an email.

Palatnick said the app had to use the same algorithms as traditional genomics software running on supercomputers to ensure that iGenomics was accurate and practical. Building algorithms capable of rendering DNA alignments and mutations as users tapped, scrolled and pinched the views presented a technical hurdle, Palatnick wrote.

While Schatz is optimistic about the vaccinations that health care workers are now receiving, he said a mass vaccination program introduces new pressure on the virus.

“We and everyone else are watching with great interest to see if [the vaccinations] cause the virus to mutate,” Schatz said. “That’s the big fear.”

Working with the sequences from Nanopore technology, iGenomics can compare the entire genome to known problematic sequences quickly. Users need to get the data off the Oxford Nanopore device and onto the app. They can do that using email, from Dropbox or the web. 

In prior viral outbreaks, epidemiologists traveled with heavier equipment to places like West Africa to monitor the genome of Ebola or to South and Central America to study the Zika virus genome.

“There’s clearly a strong need to have this capability,” Schatz said.

Another iGenomics feature is that it allows users to airdrop any information to people, even when they don’t have internet access.

Schatz urged users to ensure that they use a cloud-based system with strong privacy policies before considering such approaches, particularly with proprietary data or information for which privacy is critical.

As for COVID-19, people with the disease have shown enough viral mutations that researchers can say whether the strain originated in Europe or China.

“It’s kind of like spelling mistakes,” Schatz said. “There are enough spelling mistakes where [researchers] could know where it came from.”

Palatnick described iGenomics as an “impactful” tool because the app has increased the population of people who can explore the genome from institutional researchers to anyone with an iPhone or iPad.

In the bigger picture, Schatz is broadly interested in learning how the genome creates differences.

“It’s important to understand these messages for the foods we eat, the fuels we use, the medicines we take,” Schatz said. “The next frontier is all about interpretation. One of the most powerful techniques is comparing one genome to another.”

Schatz seeks out collaborators in a range of fields and at numerous institutions, including Cold Spring Harbor Laboratory.

Schatz and W. Richard McCombie, Professor at CSHL, are studying the genomes of living fossils. These are species that haven’t evolved much over millions of years. They are focusing on ancient trees in Australia that have, more or less, the same genetic make up they did 100 million years ago.

As for Palatnick, Schatz described his former intern and tricorder creating partner as a “superstar in every way.” Schatz said it takes considerable fortitude in science, in part because it takes years to go from an initial idea on a napkin to something real.

Down the road, Schatz wouldn’t be surprised if Palatnick took what he learned and developed and contributed to the founding of the next Twitter or Facebook.

“He has that kind of personality,” Schatz said.

Brandy. Photo from Pixabay

By Bob Lipinski

Bob Lipinski

Armagnac is a brandy distilled from wine and is often confused with its close cousin, Cognac. However, Armagnac’s taste is fuller and richer and is described as less “burning” and more mellow. Armagnac comes from the Gascony region in southwest France, 150 miles southeast of Bordeaux and 100 miles south of Cognac.

Armagnac has been distilled in Gascony since 1411, making it the world’s oldest brandy. In the mid-1600s the Dutch first exported it, and the aging of brandy in wooden barrels seems to have been practiced since 1730. In 1936 the Armagnac region was divided into three appellations: Haut-Armagnac, Bas-Armagnac, and Armagnac-Ténarèze. The best quality Armagnac comes from the Bas-Armagnac appellation, which produces over 55 percent of the region’s brandy.

Armagnac is produced principally from Ugni Blanc, Colombard, Folle Blanche, and Baco Blanc grapes. The wine is distilled to produce a colorless brandy with a powerful bouquet and flavor described as “firewater.” Approximately 95 percent of the brandy undergoes only one distillation.

Armagnac is aged in black, tannic-rich, 400-liter oak barrels from the Monlezun forest of France in the Bas-Armagnac. However, wood from Limousin, Allier, and Tronçais forests are being used because Monlezun forests have dwindled.

After aging, the brandies of different appellations and ages are blended. Following blending, the strength of the Armagnac is reduced to 40 or 43 percent alcohol by distilled water. This is followed by adding caramel for color “adjustment” if needed. Armagnac is then kept in large barrels for additional months to allow for the curing or “marrying” of the blend.

Legislation states that a vintage date on the label of a bottle of Armagnac indicates year of harvest, not year of distillation.

Label designations

• VS or three-star. Minimum three years old

• VSOP or Napoléon. Minimum four years old

• XO or Hors d’Age. Minimum 10 years old

• XO Premium. Minimum 20 years old

• Vintage. Minimum 10 years old

Taste

Depending on the type and age, Armagnac can have aromas and flavors of flowers, caramel, toffee, cinnamon, coconut, hazelnuts, dried fruit, fresh fruit (apricot, orange, peach, plum, prune, raspberry), maple syrup, roses, spices, violets, and vanilla.

Serving Armagnac

Armagnac has traditionally been regarded as an after-dinner drink, but in some countries, it is served before or with a meal. Purists prefer to enjoy the older, finer Armagnac unmixed. Armagnac should be served in short tulip-shaped glasses tall enough to allow a reasonable aroma to build, yet small enough to be cradled in one’s hand.

Bob Lipinski is the author of 10 books, including “101: Everything You Need To Know About Whiskey” and “Italian Wine & Cheese Made Simple” (available on Amazon.com). He conducts training seminars on Wine, Spirits, and Food and is available for speaking engagements. He can be reached at www.boblipinski.com OR [email protected].

METRO photo

By Barbara Beltrami

In case you haven’t noticed, the ongoing theme of my recent columns has been coping with and compensating for COVID restrictions while celebrating the holidays. So here I go again. I believe that whether you’re alone or with just your immediate family (and I do hope for your sake and everyone else’s that it won’t be more than that), you should make the holiday as merry as you can. 

A great way to do that for Christmas Eve or Christmas dinner is to carry out the red and green theme in as many dishes as possible. It doesn’t have to be fancy, but it does have to be festive. I’m thinking that spinach lasagna rollups might do the trick paired with a butter lettuce and arugula salad with bell pepper confetti and a pomegranate vinaigrette. Then for dessert, how about a parfait of pistachio or mint chocolate chip ice cream with fresh raspberry sauce? These are just a few ideas. Raid your refrigerator, shop early and come up with your own red and green Christmas dishes.

Spinach Lasagna Rollups

YIELD: Makes 6 servings

INGREDIENTS: 

For the sauce:

2 tablespoons extra virgin olive oil

1 cup finely chopped onion

Salt and freshly ground pepper to taste

2 garlic cloves, minced

One 28-ounce can crushed tomatoes

1/4 cup chopped basil

Salt and pepper to taste

For the rollups:

Nonstick cooking spray

12 lasagna noodles (not no-boil)

One 16-ounce container ricotta cheese

Half a 10-ounce box frozen chopped spinach, thawed and all liquid squeezed out

3/4 cup freshly grated Parmesan cheese

1 large egg

1 handful fresh Italian flat-leaf parsley leaves, chopped

Salt and freshly ground pepper to taste

3 cups(or more) tomato sauce to taste

1 cup shredded mozzarella

DIRECTIONS: 

In a medium saucepan warm oil over medium heat; add onions, salt and pepper and cook, stirring frequently, until they become transparent, about 5 minutes. Add garlic and cook, stirring frequently, until it releases its aroma, about 30 seconds. Add tomatoes, basil, salt and pepper and a few tablespoons water and cook over medium heat, stirring frequently, until sauce is thickened and liquid is evaporated, about 15 minutes.

Preheat oven to 350 F; coat a shallow baking pan with nonstick cooking spray. Cook lasagna noodles according to package directions and drain, then lay out in baking pan.

In a medium bowl thoroughly combine the ricotta, spinach, Parmesan cheese, egg, parsley, salt and pepper. Spread a thin layer of tomato sauce on bottom of baking pan spread ricotta mixture evenly along each noodle, then top with a thin layer of tomato sauce and carefully roll up; place seam side down evenly in baking dish and spoon remaining sauce over them. Sprinkle mozzarella on top. Bake until they are heated through, sauce is bubbly and mozzarella has melted, about 20 minutes. Serve hot with arugula and butter lettuce salad.

Arugula and Butter Lettuce Salad with Pomegranate Vinaigrette

YIELD: Makes 6 servings

INGREDIENTS: 

1 large bunch arugula, washed and stems removed

1head butter lettuce or Boston lettuce

6 radishes, cleaned and cut into matchstick-size strips

1/2 cup fresh or bottled pomegranate juice

1/4 cup red wine vinegar

1 tablespoon balsamic vinegar

2 to 3 tablespoons honey

1 teaspoon prepared mustard

Salt and freshly ground black pepper to taste

Seeds from half a pomegranate

1/2 green bell pepper, seeded and finely diced

1/2 red bell pepper, seeded and finely diced

DIRECTIONS: 

In a large salad bowl, toss together the arugula, lettuce and radishes. In a small mixing bowl, whisk together the pomegranate juice, vinegars, honey, mustard, and salt and pepper. Just before serving, toss the salad with the dressing, then sprinkle with pomegranate seeds and diced peppers. Serve immediately at room temperature with lasagna rollups.

Fresh Raspberry Sauce

YIELD: Makes 1 1/2 cups

INGREDIENTS: 

3/4 pound fresh raspberries, picked over

2 tablespoons sugar or to taste

1/2 tablespoon water

1 tablespoon freshly squeezed lemon juice

DIRECTIONS: 

In a medium saucepan over medium heat, combine the berries, sugar, water and lemon juice. Stirring frequently, cook until sugar dissolves, raspberries fall apart and sauce bubbles, about 5 minutes. Remove from heat and press through a fine mesh strainer to remove seeds. Cool to room temperature, cover and refrigerate or serve warm over pistachio or mint chocolate chip ice cream accompanied by Christmas cookies.

Photo by Tom Caruso

THE LITTLE CAROLER

Tom Caruso of Smithtown snapped this photo while in Port Jefferson on Nov. 27. He writes, ‘It was nighttime and my wife and son were strolling down the streets in the village taking in the holiday sights. I spotted this doll in a shop window and the lighting perfectly painted the doll’s face against the darkened store’s interior. I couldn’t resist it.

Send your Photo of the Week to [email protected]

 

Stock photo

If only every main road could be a downtown. The ones we know and love, the ones with walkable streets, sights to see, unique restaurants to eat at, a feeling that life is being lived there at every level. 

Though of course anything is better than driving down the highway and passing by the umpteenth empty strip mall, with enough “for rent” signs to recreate a new mall entirely.

And it makes it that much more glaring when it seems every developer focuses on the new — of a new apartment complex or a new shopping mall or a new medical park — all ignoring the multitudes of empty complexes dotting the Long Island landscape. New development, especially that which plows ahead without concern for the neighborhood, next leads to issues of congestion and the impact on the environment. Meanwhile, local electeds are vying for shrinking pots of funds to buy up and preserve land that keeps the environmental vistas, as we have on the North Shore, viable and serene. There will never be enough money to buy up every stretch of forest or meadow or beach. 

Reporting on North Shore Long Island sometimes feels like watching a hoard of starving animals vying for the smallest strip of meat, as discarded carcasses rot not 5 feet away.

That’s why the Town of Brookhaven’s plans for a so-called commercial redevelopment district zoning are so interesting, because it seems like one of the few real efforts we at TBR News Media have seen toward incentivizing rebuilding instead of new development. Though we also hope that such developer incentives can find ways around abuse, especially when too many developers are already incentivized to build with things like Industrial Development Agency tax deals.

Brookhaven’s proposed CRD special zoning, as proposed, will only be available to those property owners who can prove they are redesigning aging property with walkability, livability and commercial interests all in one. Such applications for that special zoning will also be at the discretion of the Town Board.

If the idea pans out, it could mean a massive push toward revitalization in places such as Port Jefferson Station. If it does what it’s intended to do, other towns like Smithtown or Huntington, who are suffering their own ills of vacant stores and strip malls, could adopt something similar as well. It would be nice, for a change, to hear from a developer about redesigning an eyesore rather than the usual plan to pave paradise to put up a parking lot.

Though we also have to share our reservations. Developers are already well incentivized throughout Suffolk County to build anew, especially with a multitude of deals coming from IDAs at both the county and town level. In Port Jefferson, for example, every single new apartment complex in the past several years has been given a payment-in-lieu-of-taxes deal by the Brookhaven Industrial Development Agency. While IDA board members say such projects will contribute to the economy, these new developments hardly add any significant job numbers to the local economy once the building process is complete. 

Brookhaven’s CRD zoning intends that developers will get more leeway on applications for rebuilding based on location or how many amenities there are — such as green space or places for social activity. The risk is that these same builders will find ways to take advantage of these deals while still getting IDA money. Such a new zoning will need even greater scrutiny on applications than is already happening at the town level. A bike rack here or there isn’t worth as much to a community as a new location’s property taxes.

Still, overall, we think this could be a great leap in the right direction. We hope both local developers and local government are up to the task of revitalizing the commercial areas too long neglected.

Photo from Pixabay
Daniel Dunaief

I have brought three fictional characters in to discuss their thoughts for 2021. Please welcome Yoda from the “Star Wars” series, Jack Ryan from Tom Clancy books, and Jane Craig from the film “Broadcast News.” I will call you all by your first names. Well, except for you, Yoda.

TBR: After such a tumultuous 2020, I wanted to ask you what you all thought would likely happen next year.

Yoda: Tough to say, the future is. If the answers you don’t like, the questions you must change.

Jack: Look, I’m not sure what we’re doing here, but I think the vaccine offers real hope for change. Your world, such as it is, should be able to move in the right direction.

Jane: The trends at this point are horrific. You have enormous numbers of positive tests each day, hospitalizations are up and the number of dead continues to rise.

TBR: Yoda, you’re kind of off point and sound like a backwards fortune cookie. Jack, I appreciate the optimism and Jane, I think you’re focusing on the negatives.

Jane: We can’t preclude the possibility that the positive infections will continue to climb for months. While it’d be swell to have a big party to celebrate the vaccine and the return to whatever version of normal each of us has, it’s important that we protect ourselves and our families.

Jack: She’s right. Everyone doesn’t have the vaccine and everyone hasn’t taken it, which means we won’t reach herd immunity for a while. While this is killing the entertainment industry, among so many others, it’s necessary for us to sit tight for a while. At the same time, we need to consider the possibility that other governments will become opportunistic about this messy transition at the White House. We need to protect ourselves and remain vigilant. This is a dangerous time, in so many ways, and we need to analyze all kinds of traffic.

Yoda: Know something about vigilance, do I. Messy, this world has become. Goodness, hope and optimism, there remains. Effort to get there will it take.

TBR: Jane, this question, in particular, seems right up your alley. What do you think about the news business in 2021?

Jane: I’m not going to lie to you, it’s been a tough year for everyone, particularly in the news business. We are not the enemy. When we do our jobs well, people get to hear the truth. They can make informed decisions that affect their lives. Are there problems? Of course, but that doesn’t make the entire industry corrupt, any more than it would in any other business.

Yoda: Inside each of us, the enemy resides. Confront it, we must.

Jack: I’ve dealt with journalists all the time. They are a competitive group, I’ll give them that, but they are necessary to shine light, at the right time, on everything from the fight against the virus to the battle against corrupt governments.

TBR: Do you think we’ve learned any lessons from 2020?

Jack: It’s been a brutal year and so many people have lost so much. The numbers don’t tell the entire story. We can only live with what we know: we can protect ourselves and our family through policies that have nothing to do with politics. Careful analysis and science brought us the vaccines. We need to make informed decisions about using them.

Jane: Exactly my point, Jack. We can and should make informed decisions, which the media, at its best, can support.

Yoda: Mistakes, everyone makes. Opportunities to learn, we have. Family and those fortunate enough to share life with us, we must cherish.

Photo from Pixabay

By Leah S. Dunaief

Leah Dunaief

One of my favorite days occurred this week. It is the winter solstice, usually considered to be Dec. 21 or 22. Why do I like that day, you might wonder? Some people think of it negatively as the shortest day of the year. In New York, the night was 14 hours and 45 minutes, shorter than in Minnesota at 15 hours and 50 minutes but longer than Miami at 13 hours and 28 minutes. For me it marks the turning point of the seasons, when each subsequent day then begins to have more light. Darkness will be lifting over the next six months, gradually but definitively. And for COVID-19, the pandemic of the century, it is a perfect metaphor. The vaccine is arriving at winter solstice with the promise that the disease, like the days, will lighten.

The vaccine is the match that will eventually banish the darkness. People all over the world, since the beginning of recorded history, have lit fires to ward off the night. It is not a coincidence that the birth of Jesus is celebrated at this time. Houses and trees are brightly decorated with all manner of lights. Hanukkah candles burn brightly at this same time, and in an 8-day sequence, as if prophesying the gradual lighting up of the days. Diwali is a five-day festival of Hindus, Sikhs and others, pushing back the night and celebrating the coming of more light. 

So will the vaccine, perfectly timed, gradually vanquish the pandemic over the same next few months.

Just as a point of information, I looked up the meaning of winter solstice and found the definition as the time during the earth’s orbit around the sun at which the sun is at its greatest distance from the celestial equator. So the other part of the shortest day is the winter season that we have to get through with its long days before we can enjoy more brightness and warmth. And we will also have to endure more illness and death from the novel coronavirus before we can recapture the world as we have known it. We will have to hold on, using our various strategies for survival, until what has been described as the unending “snow days” of lockdown yield to recovery.

Winter can be thought of as a time of intense cold, of scarcity, of starkness and even of death of the earth. But the earth has not died. It is merely resting, and all who live on it are forced to slow down until light and warmth bring growth. For us humans, it can be when we nest with our families, play games, watch movies, tell stories about our ancestors and fill the house with the smells of stick-to-the-rib cooking. Unfortunately, we have been doing just that, unwillingly, for the past 10 months. But the warmth and the light inside the home are especially welcome now that the wind is howling and the snow is sticking. 

When we were in Alaska some years ago, many of the residents we met said that winter was their favorite season, when members of the community come together indoors to socialize and look after each other as the elements rage in the darkness outdoors.

This winter, we will be coming together via zoom and the other miracles of modern technology. As the earth lies fallow, we can just rest. Or we can evaluate our lives and priorities, learn things that, like planted seeds, will flower in the warmth and light of the spring. We can certainly straighten out our closets and desk drawers, if we haven’t already. All the while, we can follow the guidelines of the scientists and physicians and keep ourselves safe for the spring.

This is my last column of the year. The next issue, of 12/31, will be entirely filled with stories about those heroic and tireless residents who kept life going in 2020 and richly deserve to be honored as People of the Year.

We here at TBR News Media wish you and your loved ones holidays that are happy and safe.

We look forward to rejoining you next year.